Document:

EXHIBIT 10.1

 

 Exhibit 10.1
 

 PATENT ASSIGNMENT AGREEMENT
 

 THIS PATENT ASSIGNMENT AGREEMENT (the “Agreement”) is signed by the following Parties and is effective as of 7th July, 2017 (the “Effective Date”):
 

 1.
 Zhengda Gene Life Science Shares Limited (“ZHENGDA”), a company incorporated in the Hong Kong Special Administrative Region (“Hong Kong”) of the People’s Republic of China (the “PRC”) with its registered address at Unit 04, 7/F., Bright Way Tower, No. 33 Mong Kok Road, Kowloon, Hong Kong.
 2.
 Medisun Precision Medicine Ltd. (“MPM”), a Marshall Islands Corporation with its registered address at Trust Company Complex, Ajeltake Road, Majuro, Marshall Islands MH96960.
 

 

 ARTICLE 1 – BACKGROUND
 

 1.1
 ZHENGDA hereby warrants and confirms that it is the sole beneficial owner of certain patent rights (the “Patent Rights”) applied for registration in the State Intellectual Property Office of the PRC (patent application number: 201610218242) in relation to isolation and culture method for primary mice or rat skeletal muscle cells.  A description of the Patent Rights is attached as Appendix A to this Agreement.  ZHENGDA has the right to sell, assign and transfer said Patent Rights.  It is hereby further warranted and confirmed by ZHENGDA that it has obtained all necessary consents, permits and approvals to acquire the Patent Rights, and now sells, assigns and transfers the Patent Rights, and to the best information, knowledge and belief of ZHENGDA, there is no litigation or dispute over the Patent Rights, and it is not aware that the application would be likely to be refused by the State Intellectual Property Office of the PRC. 
 

 1.2
 ZHENGDA is willing to sell, assign and transfer said Patent Rights to MPM, subject to the terms and conditions of this Agreement.
 

 1.3
 In consideration of the premises and the mutual covenants contained in this Agreement, ZHENGDA and MPM (hereinafter the “Parties” or singularly a “Party”) agree to the terms of this Agreement.
 

 

 

 

 
 

 

 ARTICLE 2 – ASSIGNMENT
 

 2.1
 Subject to the terms and conditions of this Agreement, ZHENGDA hereby sells, assigns and transfers irrevocably unto MPM, its successors and assigns, the entire interest in the said Patent Rights and all associated rights.  For the Patent Rights assigned hereunder, MPM shall issue and allot 15,000,000 of its new shares of common stock to ZHENGDA as consideration. 
 

 ARTICLE 3 – CLOSING
 

 3.1
 Closing of this Agreement shall take place on the Effective Date (the “Closing Date”) and immediately after the signing of this Agreement by the Parties, in which the following matters shall be transacted:
 

 3.1.1
 issue and allot 15,000,000 new shares of common stock of MPM to ZHENGDA; and
 

 3.1.2
 arrange to issue a share certificate of MPM to ZHENGDA certifying that ZHENGDA is the holder of the said 15,000,000 new shares of common stock.
 

 3.2
 As soon as practicable after the Closing Date, the Parties shall use their best endeavor to procure that the legal and beneficial ownership of the Patent Rights be transferred or assigned to MPM, and the Parties shall execute all such documents and conduct all such actions which are necessary to bring into effect of such transfer or assignment. All the costs of such transfer or assignment shall be borne equally between the Parties, unless otherwise agreed by the Parties. 
 

 3.3
 ZHENGDA shall use its best endeavour to assist and provide all such necessary assistance required by MPM to complete the registration of the Patent Rights at the State Intellectual Property Office of the PRC at its own costs.  The obligation under this paragraph as well as the warranty in paragraph 1.1 shall survive upon closing of this Agreement. 
 

 ARTICLE 4 – GENERAL
 

 4.1
 Unless with the written consent of the other party, the obligations or rights of this Agreement cannot be modified or transferred.
 

 

 

 

 
 

 4.2 
 This Agreement supersedes all prior agreements between the parties who recognize that any claim shall be made in respect of this Agreement. Any modifications to this Agreement need to be in writing and signed by the Parties to become effective.
 

 4.3
 This Agreement may be signed in any number of ways by the parties separately, and signed and sent by email to the other party, be deemed an original, and all separately signed documents (including some sent by email) should form the basis of this Agreement.  There shall be three copies of this Agreement, with MPM holding two and ZHENGDA holding one. 
 

 4.4
 Except where otherwise specified, time is of the essence for this Agreement.
 

 4.5
 Unless the other party agrees or disclosure is required by law, regulation or in response to a valid order of a court, no party shall disclose confidential information (including but not limited to financial information, company and customer data).   For avoidance of doubt, it is acknowledged by the Parties that MPM is a public company whose shares have been listed for trading on the OTC Markets in the United States of America, and hence MPM shall be permitted to make all such disclosures or announcements which are necessary or required under the applicable laws and regulations.  
 

 4.6
 If any jurisdiction finds any provision of this Agreement to be illegal, invalid or unenforceable, it would not affect the legitimacy of the other provisions, validity or enforceability.
 

 4.7
 The parties to this Agreement have been advised to obtain independent professional advice.
 

 4.8
 Costs and expenses associated with the transfer of the Patent Rights shall be borne by the respective Parties unless otherwise agreed.
 

 4.9
 This Agreement shall be governed by and construed in accordance with the PRC law and the Parties to the Agreement have agreed to have non-exclusive jurisdiction of the courts of the PRC.
 

 

 

 

 

 
 

 IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed by their respective authorized signatories as of the date first indicated above.
 

 

 MEDISUN PRECISION MEDICINE LTD. 
 

 

 

 By: /s/ Lisha Huang                               
                     Name:  Lisha Huang
 Title: Director
  
 

 

 

 

 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK
 ZHENGDA’S SIGNATURE PAGE FOLLOWS]
 

 

 

 

 
 

 IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed by their respective authorized signatories as of the date first indicated above.
 

 

 ZHENGDA GENE LIFE SCIENCE SHARES LIMITED
 

 

 

 By: /s/ Guofeng Yang                                  
 Name:  Guofeng Yang
 Title:  Director 
  
 

 

 

 

 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
 

 

 

 

 
 

 Appendix A
 

 Description of the Patent RightsEX-4.2

 Exhibit 4.2 
  

					
	 NUMBER
  

*PRC1*
  

THIS CERTIFICATE IS TRANSFERABLE IN NEW YORK, N.Y.
	  	 DIGITAL REALTY TRUST, INC.
  

INCORPORATED UNDER THE LAWS OF THE STATE OF MARYLAND
	  	 SHARES
  

SEE REVERSE FOR IMPORTANT NOTICE ON TRANSFER RESTRICTIONS AND OTHER INFORMATION

 
 CUSIP [•]

 THIS CERTIFIES THAT 

**SPECIMEN** 
 IS THE OWNER OF
        ** ** 
 FULLY PAID AND NONASSESSABLE SHARES OF THE 6.625% SERIES C CUMULATIVE REDEEMABLE
PERPETUAL PREFERRED STOCK, PAR VALUE $0.01 PER SHARE, OF 
 Digital Realty Trust, Inc. 

(the “Company”) transferable on the books of the Company by the holder hereof in person or by its duly authorized attorney, upon surrender of this
Certificate properly endorsed. This Certificate is not valid unless countersigned by the Transfer Agent and registered by the Registrar. 

IN WITNESS WHEREOF, the Company has caused this Certificate to be executed on its behalf by its duly authorized officers. 

 

							
	DATED                             	 		 		 	
				
	Countersigned and Registered:	 	American Stock Transfer & Trust Company, LLC	 		 	
		 	(New York, NY) Transfer Agent and Registrar	 		 	                                     
                       (SEAL)
		 		 		 	Chief Financial Officer
				
		 		 	[Seal]            	 	
			
	By:                                   
                         	 		 	  

	Authorized Signature	 		 		 	Senior Vice President, General Counsel and Secretary

 DIGITAL REALTY TRUST, INC. 

IMPORTANT NOTICE 

Classes of Stock 
 THE
COMPANY IS AUTHORIZED TO ISSUE CAPITAL STOCK OF MORE THAN ONE CLASS, CONSISTING OF COMMON STOCK AND ONE OR MORE CLASSES OF PREFERRED STOCK. THE BOARD OF DIRECTORS IS AUTHORIZED TO DETERMINE THE PREFERENCES, LIMITATIONS AND RELATIVE RIGHTS OF ANY
CLASS OF THE PREFERRED STOCK BEFORE THE ISSUANCE OF SHARES OF SUCH CLASS OF PREFERRED STOCK. THE COMPANY WILL FURNISH, WITHOUT CHARGE, TO ANY STOCKHOLDER MAKING A WRITTEN REQUEST THEREFOR, A COPY OF THE COMPANY’S CHARTER AND A WRITTEN STATEMENT
OF THE DESIGNATIONS, RELATIVE RIGHTS, PREFERENCES, CONVERSION OR OTHER RIGHTS, VOTING POWERS, RESTRICTIONS, LIMITATIONS AS TO DIVIDENDS AND OTHER DISTRIBUTIONS, QUALIFICATIONS AND TERMS AND CONDITIONS OF REDEMPTION OF THE STOCK OF EACH CLASS WHICH
THE COMPANY HAS THE AUTHORITY TO ISSUE AND, IF THE COMPANY IS AUTHORIZED TO ISSUE ANY PREFERRED OR SPECIAL CLASS IN SERIES, (i) THE DIFFERENCES IN THE RELATIVE RIGHTS AND PREFERENCES BETWEEN THE SHARES OF EACH SERIES TO THE EXTENT SET, AND
(ii) THE AUTHORITY OF THE BOARD OF DIRECTORS TO SET SUCH RIGHTS AND PREFERENCES OF SUBSEQUENT SERIES. REQUESTS FOR SUCH WRITTEN STATEMENT MAY BE DIRECTED TO THE SECRETARY OF THE COMPANY AT ITS PRINCIPAL OFFICE. 

Restriction on Ownership and Transfer 

THE SHARES OF THE COMPANY’S 6.625% SERIES C CUMULATIVE REDEEMABLE PERPETUAL PREFERRED STOCK (“SERIES C PREFERRED STOCK”)
REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON BENEFICIAL AND CONSTRUCTIVE OWNERSHIP AND TRANSFER FOR THE PURPOSE OF THE COMPANY’S MAINTENANCE OF ITS STATUS AS A REAL ESTATE INVESTMENT TRUST UNDER THE INTERNAL REVENUE CODE OF
1986, AS AMENDED (THE “CODE”). SUBJECT TO CERTAIN FURTHER RESTRICTIONS AND EXCEPT AS EXPRESSLY PROVIDED IN THE ARTICLES SUPPLEMENTARY FOR THE SERIES C PREFERRED STOCK, (i) NO PERSON MAY BENEFICIALLY OR CONSTRUCTIVELY OWN SHARES OF
SERIES C PREFERRED STOCK IN EXCESS OF 9.8% (BY VALUE OR BY NUMBER OF SHARES, WHICHEVER IS MORE RESTRICTIVE) OF THE OUTSTANDING SERIES C PREFERRED STOCK OF THE COMPANY; (ii) NO PERSON MAY BENEFICIALLY OR CONSTRUCTIVELY OWN SHARES OF SERIES C
PREFERRED STOCK THAT, TAKING INTO ACCOUNT ANY OTHER CAPITAL STOCK OF THE COMPANY BENEFICIALLY OR CONSTRUCTIVELY OWNED BY SUCH PERSON, WOULD RESULT IN SUCH PERSON BENEFICIALLY OR CONSTRUCTIVELY OWNING CAPITAL STOCK WITH A VALUE IN EXCESS OF 9.8% OF
THE VALUE OF THE COMPANY’S OUTSTANDING CAPITAL STOCK; (iii) NO PERSON MAY BENEFICIALLY OR CONSTRUCTIVELY OWN SHARES OF SERIES C PREFERRED STOCK THAT, TAKING INTO ACCOUNT ANY OTHER CAPITAL STOCK OF THE COMPANY BENEFICIALLY OR CONSTRUCTIVELY
OWNED BY SUCH PERSON, WOULD RESULT IN THE COMPANY BEING “CLOSELY HELD” UNDER SECTION 856(h) OF THE CODE OR OTHERWISE CAUSE THE COMPANY TO FAIL TO QUALIFY AS A REIT; AND (iv) ANY TRANSFER OF SHARES OF SERIES C PREFERRED STOCK THAT, IF
EFFECTIVE, WOULD RESULT IN THE CAPITAL STOCK OF THE COMPANY BEING BENEFICIALLY OWNED BY FEWER THAN 100 PERSONS WILL BE VOID AB INITIO AND THE INTENDED TRANSFEREE WILL ACQUIRE NO RIGHTS IN SUCH SHARES OF SERIES C PREFERRED STOCK. ANY PERSON WHO
BENEFICIALLY OR CONSTRUCTIVELY OWNS OR ATTEMPTS TO BENEFICIALLY OR CONSTRUCTIVELY OWN SERIES C PREFERRED STOCK WHICH CAUSES OR WILL CAUSE A PERSON TO BENEFICIALLY OR CONSTRUCTIVELY OWN SERIES C PREFERRED STOCK IN EXCESS OF THE ABOVE LIMITATIONS MUST
IMMEDIATELY NOTIFY THE COMPANY. IF ANY OF THE RESTRICTIONS ON TRANSFER OR OWNERSHIP IN (i) THROUGH (iii) ABOVE ARE VIOLATED, THE SERIES C PREFERRED STOCK REPRESENTED HEREBY IN EXCESS OF SUCH RESTRICTIONS WILL BE AUTOMATICALLY TRANSFERRED
TO THE TRUSTEE OF A TRUST FOR THE BENEFIT OF ONE OR MORE CHARITABLE BENEFICIARIES. IN ADDITION, THE COMPANY MAY REDEEM SHARES UPON THE TERMS AND CONDITIONS SPECIFIED BY THE BOARD OF DIRECTORS IN ITS SOLE DISCRETION IF THE BOARD OF DIRECTORS
DETERMINES THAT OWNERSHIP OR A TRANSFER OR OTHER EVENT MAY VIOLATE THE RESTRICTIONS DESCRIBED ABOVE. FURTHERMORE, UPON THE OCCURRENCE OF CERTAIN EVENTS, ATTEMPTED TRANSFERS IN VIOLATION OF THE RESTRICTIONS DESCRIBED ABOVE MAY BE VOID AB INITIO. ALL
TERMS IN THIS LEGEND WHICH ARE DEFINED IN THE ARTICLES SUPPLEMENTARY FOR THE SERIES C PREFERRED STOCK SHALL HAVE THE MEANINGS ASCRIBED TO THEM IN SUCH ARTICLES SUPPLEMENTARY, AS THE SAME MAY BE AMENDED FROM TIME TO TIME, A COPY OF WHICH, INCLUDING
THE RESTRICTIONS ON TRANSFER AND OWNERSHIP, WILL BE FURNISHED TO EACH HOLDER OF SERIES C PREFERRED STOCK ON REQUEST AND WITHOUT CHARGE. REQUESTS FOR SUCH A COPY MAY BE DIRECTED TO THE SECRETARY OF THE COMPANY AT ITS PRINCIPAL OFFICE. 

Keep this Certificate in a safe place. If it is lost, stolen, or destroyed, the Company will require a bond of indemnity as a condition to the issuance of a
replacement certificate. 
 The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they
were written out in full according to applicable laws or regulations: 
  

							
	TEN COM	  	-	  	as tenants in common	  	UNIF GIFT MIN ACT                      Custodian
	TEN ENT	  	-	  	as tenants by the entireties	  	                                    (Custodian) 
        (Minor)
	JT TEN	  	-	  	as joint tenants with right of	  	under Uniform Gifts to Minors Act of
		  		  	survivorship and not as tenants	  	                                      
                      
		  		  	in common	  	(State)

 Additional abbreviations may also be used though not in the above list. 

FOR VALUE RECEIVED,
                                         
                                         
                           DOES HEREBY SELL, ASSIGN AND TRANSFER UNTO 

 

	
	PLEASE INSERT SOCIAL SECURITY OR OTHER 
IDENTIFYING NUMBER OF ASSIGNEE
	 

  
  

(Please Print or Typewrite Name and Address, Including Zip Code, of Assignee) 

 
  
  

 
  

 
 shares of the 6.350% Series C Cumulative Redeemable
Perpetual Preferred Stock represented by the within Certificate and does hereby irrevocably constitute and appoint 
  

 
 to transfer the said stock on the books of the within
named Company with full power of substitution in the premises. 
 Dated
                     
  

			
	X	 	  

		
	X	 	  

		
	NOTICE:	 	THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAMES AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATEVER.

 Signature(s) Guaranteed 
  

	
	By                                      
                                         
             
	THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C.
RULE 17Ad-15.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}]]